Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Goodwill & Intangibles (2016 - 2024)

Historic Goodwill & Intangibles for Sanofi (SNY) over the last 17 years, with Q3 2025 value amounting to $80.5 billion.

  • Sanofi's Goodwill & Intangibles changed N/A to $80.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $80.5 billion, marking a year-over-year change of. This contributed to the annual value of $70.5 billion for FY2024, which is 1154.43% down from last year.
  • Sanofi's Goodwill & Intangibles amounted to $80.5 billion in Q3 2025.
  • Sanofi's Goodwill & Intangibles' 5-year high stood at $80.5 billion during Q3 2025, with a 5-year trough of $45.6 billion in Q2 2025.
  • Moreover, its 5-year median value for Goodwill & Intangibles was $67.1 billion (2025), whereas its average is $64.7 billion.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first soared by 868.89% in 2023, then plummeted by 1544.91% in 2025.
  • Over the past 5 years, Sanofi's Goodwill & Intangibles (Quarter) stood at $79.5 billion in 2021, then dropped by 8.16% to $73.0 billion in 2022, then grew by 8.69% to $79.3 billion in 2023, then fell by 11.07% to $70.5 billion in 2024, then increased by 14.13% to $80.5 billion in 2025.
  • Its last three reported values are $80.5 billion in Q3 2025, $45.6 billion for Q2 2025, and $67.1 billion during Q1 2025.